David Gryska
Equibles does not estimate personal net worth.
Get an email with a short summary when Definium Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get DFTX alertsAbout David Gryska
David Gryska is recorded as CFO at Definium Therapeutics, Inc. (DFTX). The newest filing on record that lists David Gryska as CFO at Definium Therapeutics, Inc. (DFTX) is dated April 27, 2026. Earlier roles on record: Board Member at Forte Biosciences, Inc. until August 27, 2026. Definium Therapeutics, Inc. reported in an 8-K filed June 12, 2026 that David Gryska was appointed Director, effective June 11, 2026. Definium Therapeutics, Inc. reported in an 8-K filed June 16, 2025 that David Gryska was appointed member of the Board, effective June 12, 2025. Definium Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Definium Therapeutics, Inc. includes Dr. Roger Crystal (CEO), Dr. Suzanne Bruhn (CEO), JR Rahn (CEO) and 7 others.
“The Company's seven nominees, Robert Barrow, Dr. Suzanne Bruhn, Dr. Roger Crystal, David Gryska, Andreas Krebs, Carol A. Vallone, and Roger Adsett, were each elected to serve as a member of the Board until the 2027 annual general meeting of shareholders (the "2027 Annual Meeting") or until a successor has been duly elected or appointed, by the following votes:”
“The Company's six nominees, Robert Barrow, Dr. Suzanne Bruhn, Dr. Roger Crystal, David Gryska, Andreas Krebs, and Carol A. Vallone, were each elected to serve as a member of the Board until the 2026 annual general meeting of shareholders (the "2026 Annual Meeting") and until his or her successor is duly elected or qualified, by the following votes:”
Affiliation history
-
Current
Start not stated–present
Last confirmed April 27, 2026
-
2023-01-01–2025-04-23
Last confirmed by a filing; no departure on record
-
Forte Biosciences, Inc.
Board Member
Proxy statement
2023-01-01–2026-08-27
Company network
Forte Biosciences, Inc.
Biotechnology · Healthcare
Board Member
2023-01-01–2026-08-27
Leadership on record at Definium Therapeutics, Inc.
- Dr. Roger Crystal CEO
- Dr. Suzanne Bruhn CEO
- JR Rahn CEO
- Robert Barrow CEO
- Stephen Hurst CEO
- Carol A. Vallone Chairman
- Brandi L. Roberts CFO
- Roger Adsett COO, Board Member
- Carrie F. Liao Chief Accounting Officer
- Andreas Krebs Board Member